The 3rd AMR Accelerator Cross-project Meeting for the AMR Accelerator community, a total of 9 projects, took place on 06 April 2022 in Basel, Switzerland. Please find more details here and the final agenda below: DOWNLOAD THE FULL PROGRAMME HERE DOWNLOAD THE PRESENTATIONS HERE
After two years of digital AMR Conferences, we will finally meet each other in person for the 6th AMR Conference 2022 in Basel, Switzerland. Looking forward to see you there! Sign up for our AMR newsletter to stay updated about the status of further planning as well as other AMR-related news.
In June 2022, the Paul-Ehrlich-Institut organised a two-day virtual expert workshop on behalf of the COMBINE project. The workshop aimed to address the challenges in developing monoclonal antibodies (mAbs) against antimicrobial resistance (AMR) pathogens, with a specific focus on ESCAPE pathogens (E. faecium, S. aureus, C. difficile, A. baumannii, P. aeruginosa, and Enterobacteriaceae). The workshop […]
JPIAMR in partnership with the Medical Research Council (MRC UKRI) are hosting a workshop on antibiotic resistance, specifically looking for input from Early to Mid-Career Researchers. Antibiotic resistance is prevalent in bacterial infections across the world, threatening many of the fundamentals of modern medicine. A huge amount of work and funding has been focussed on […]
A 30-minute public webinar will be held on June 9, 2022 at 09:00 AM EDT with representatives from CARB-X, BARDA, Wellcome and NIAID to discuss the global health issues of AMR, and how CARB-X and its partners are working together to address them. The webinar celebrates a recent announcement in which BARDA and Wellcome have committed up to an additional […]
Vaccination programs are known to be effective to both promote the prudent use of antibiotics and to prevent the spread of AMR. JPIAMR, in partnership with the Medical Research Council and BactiVac Network, are holding a live webinar to identify opportunities and priorities for vaccine research from an immunological perspective to a wider translational context, in the field […]
The prosperity of the modern world is threatened by the emergence of drug resistant pathogens, pesticide-resistant insects and herbicide-resistant weeds. Novel investigational cancer drugs increase life expectancy, but fail when resistance develops. The same principles of evolution drive the development of resistance in all of these contexts, yet each field attacks the problem of resistance […]
Recap of the third UNITE4TB webinar: Progress made to date in shortening TB treatment UNITE4TB held its third public webinar on Thursday 7 July, with a focus on the recent changes in the World Health Organization (WHO) guidelines for the treatment of Tuberculosis (TB) and an evaluation of the evidence underpinning the shortening of TB […]
The prosperity of the modern world is threatened by the emergence of drug resistant pathogens, pesticide-resistant insects and herbicide-resistant weeds. Novel investigational cancer drugs increase life expectancy, but fail when resistance develops. The same principles of evolution drive the development of resistance in all of these contexts, yet each field attacks the problem of resistance […]
On 26 July, James J. Collins and Richard Lee will be discussing the use of Synthetic biology and interdisciplinary approaches for antibiotic discovery.
